title: Late onset atypical pantothenate-kinase-associated neurodegeneration.
abstract: Introduction. Pantothenate-kinase-associated neurodegeneration (PKAN) is a rare genetic disease and a form of neurodegeneration with brain iron accumulation (NBIA). It most commonly begins in the first two decades of life but should be considered in the differential diagnosis of patients at any age with an atypical progressive extrapyramidal disorder and cognitive impairment. Few late-adult cases have been reported. Case Report. A 50-year-old woman presented with a history of progressive dysarthria and dysphagia secondary to orolingual dystonia. Initial work-up was normal. There was no family history. Her initial symptoms were followed by the onset of blepharospasm, cervical dystonia, Parkinsonism, and cognitive impairment. Follow-up MRI four years after presentation revealed the diagnostic "eye-of-the-tiger" sign. Genetic testing confirmed a homozygous missense mutation consistent with the diagnosis of PKAN. Conclusion. Although PKAN is a rare genetic disorder most commonly seen in childhood, it should be considered in adult patients with a history of progressive focal dystonia or atypical Parkinsonism. As the radiographic findings are quite characteristic, genetic testing should be performed if the MRI shows evidence of iron accumulation. Optimal treatment strategies are not known, and at the current time therapies should be directed at the specific manifestations of the disease.
authors: Los Angeles Biomedical Institute, Harbor-UCLA Medical Center, Box No. 492, 1000 W. Carson Street, Los Angeles, Torrance, CA 90509, USA.
authors: Natalie
authors: N
authors: Diaz
references: Mov Disord. 2011 Aug 1;26(9):1756-9
references: 21557313
references: Mov Disord. 2010 Jul 30;25(10):1424-31
references: 20629144
references: Ann Neurol. 2006 Feb;59(2):248-56
references: 16437574
references: Nat Genet. 2001 Aug;28(4):345-9
references: 11479594
references: Nat Genet. 1996 Dec;14(4):479-81
references: 8944032
references: Haematologica. 2011 Nov;96(11):1708-11
references: 21791473
references: Ann N Y Acad Sci. 2004 Mar;1012:282-98
references: 15105273
references: Arch Dis Child. 2008 Mar;93(3):239-40
references: 18319387
references: Mol Genet Metab. 2012 Mar;105(3):463-71
references: 22221393
references: Arch Neurol. 2006 Feb;63(2):292-3
references: 16476823
references: Actas Esp Psiquiatr. 2011 Jul-Aug;39(4):260-2
references: 21769749
references: Neuropediatrics. 2011 Aug;42(4):159-62
references: 21877312
references: Ann Neurol. 1985 Oct;18(4):482-9
references: 4073841
references: Mov Disord. 2005 Jul;20(7):880-6
references: 15834858
references: Mov Disord. 2006 Mar;21(3):417-8
references: 16267847
references: Eur J Neurol. 2007 Nov;14(11):e1-2
references: 17956429
references: Hum Mol Genet. 2003 Feb 1;12(3):321-7
references: 12554685
references: Muscle Nerve. 2003 Jul;28(1):118-22
references: 12811783
references: Acta Psychiatr Scand. 2003 Nov;108(5):394-7; discussion 397-8
references: 14531762
references: Mov Disord. 2006 Dec;21(12):2255-7
references: 17078094
references: J Inherit Metab Dis. 2005;28(6):1055-64
references: 16435199
references: Ann Neurol. 2005 May;57(5):738-41
references: 15852393
references: Hum Mol Genet. 2005 Jan 1;14(1):49-57
references: 15525657
references: Mov Disord. 2006 Feb;21(2):252-4
references: 16149094
references: J Inherit Metab Dis. 2007 Jun;30(3):310-7
references: 17429753
references: J Clin Neurol. 2009 Dec;5(4):192-4
references: 20076801
references: Pediatr Neurol. 2001 Aug;25(2):166-9
references: 11551748
references: N Engl J Med. 2003 Jan 2;348(1):33-40
references: 12510040